APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angiopoietin 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Angiopoietin 1 Receptor Industry Growth and Trends Forecast to 2032

19 December 202592 pages

Choose your research edition.

Industry ResearchAngiopoietin 1 Receptor Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiopoietin 1 Receptor Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Angiopoietin 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiopoietin 1 Receptor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiopoietin 1 Receptor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Angiopoietin 1 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Angiopoietin 1 Receptor include Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., PharmAbcine, Inc., Exelixis, Inc., Eddingpharm, Deciphera Pharmaceuticals, LLC and Aerpio Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Angiopoietin 1 Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Angiopoietin 1 Receptor market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Angiopoietin 1 Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Angiopoietin 1 Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Angiopoietin 1 Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Angiopoietin 1 Receptor Market by Company

Teva Pharmaceutical Industries Ltd.

Sanofi

Pfizer Inc.

PharmAbcine, Inc.

Exelixis, Inc.

Eddingpharm

Deciphera Pharmaceuticals, LLC

Aerpio Therapeutics, Inc.

Angiopoietin 1 Receptor Segment by Type

AP-185

ARP-1536

MAN-01

PMC-001

Others

Angiopoietin 1 Receptor Segment by Application

Ureter Cancer

Neuroendocrine Tumors

Ovarian Cancer

Bladder Cancer

Others

Angiopoietin 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiopoietin 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiopoietin 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiopoietin 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Angiopoietin 1 Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Angiopoietin 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AP-185 Table 2. Major Company of ARP-1536 Table 3. Major Company of MAN-01 Table 4. Major Company of PMC-001 Table 5. Major Company of Others Table 6. Global Angiopoietin 1 Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 8. Global Angiopoietin 1 Receptor Sales Market Share in Volume by Type (2021-2026) Table 9. Global Angiopoietin 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 10. Global Angiopoietin 1 Receptor Sales Market Share in Value by Type (2021-2026) Table 11. Global Angiopoietin 1 Receptor Price by Type (2021-2026) & (US$/Unit) Table 12. Global Angiopoietin 1 Receptor Sales by Type (2027-2032) & (W Units) Table 13. Global Angiopoietin 1 Receptor Sales Market Share in Volume by Type (2027-2032) Table 14. Global Angiopoietin 1 Receptor Sales by Type (2027-2032) & (US$ Million) Table 15. Global Angiopoietin 1 Receptor Sales Market Share in Value by Type (2027-2032) Table 16. Global Angiopoietin 1 Receptor Price by Type (2027-2032) & (US$/Unit) Table 17. North America Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 18. North America Angiopoietin 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 20. Europe Angiopoietin 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Angiopoietin 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 24. Latin America Angiopoietin 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Angiopoietin 1 Receptor Sales by Type (2021-2026) & (US$ Million) Table 27. Angiopoietin 1 Receptor Industry Trends Table 28. Angiopoietin 1 Receptor Industry Drivers Table 29. Angiopoietin 1 Receptor Industry Opportunities and Challenges Table 30. Angiopoietin 1 Receptor Industry Restraints Table 31. Global Angiopoietin 1 Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Angiopoietin 1 Receptor Revenue Market Share by Company (2021-2026) Table 33. Global Angiopoietin 1 Receptor Sales by Company (2021-2026) & (W Units) Table 34. Global Angiopoietin 1 Receptor Sales Share by Company (2021-2026) Table 35. Global Angiopoietin 1 Receptor Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Angiopoietin 1 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Angiopoietin 1 Receptor Major Company Production Sites and Headquarters Table 38. Global Angiopoietin 1 Receptor Company, Product Type & Application Table 39. Global Angiopoietin 1 Receptor Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Angiopoietin 1 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Angiopoietin 1 Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Angiopoietin 1 Receptor Sales by Region (2021-2026) & (W Units) Table 44. Global Angiopoietin 1 Receptor Sales Market Share in Volume by Region (2021-2026) Table 45. Global Angiopoietin 1 Receptor Sales by Region (2021-2026) & (US$ Million) Table 46. Global Angiopoietin 1 Receptor Sales Market Share in Value by Region (2021-2026) Table 47. Global Angiopoietin 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Angiopoietin 1 Receptor Sales by Region (2027-2032) & (W Units) Table 49. Global Angiopoietin 1 Receptor Sales Market Share in Volume by Region (2027-2032) Table 50. Global Angiopoietin 1 Receptor Sales by Region (2027-2032) & (US$ Million) Table 51. Global Angiopoietin 1 Receptor Sales Market Share in Value by Region (2027-2032) Table 52. Global Angiopoietin 1 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Angiopoietin 1 Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 55. Global Angiopoietin 1 Receptor Sales Market Share in Volume by Application (2021-2026) Table 56. Global Angiopoietin 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 57. Global Angiopoietin 1 Receptor Sales Market Share in Value by Application (2021-2026) Table 58. Global Angiopoietin 1 Receptor Price by Application (2021-2026) & (US$/Unit) Table 59. Global Angiopoietin 1 Receptor Sales by Application (2027-2032) & (W Units) Table 60. Global Angiopoietin 1 Receptor Sales Market Share in Volume by Application (2027-2032) Table 61. Global Angiopoietin 1 Receptor Sales by Application (2027-2032) & (US$ Million) Table 62. Global Angiopoietin 1 Receptor Sales Market Share in Value by Application (2027-2032) Table 63. Global Angiopoietin 1 Receptor Price by Application (2027-2032) & (US$/Unit) Table 64. North America Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 65. North America Angiopoietin 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 67. Europe Angiopoietin 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Angiopoietin 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 71. Latin America Angiopoietin 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Angiopoietin 1 Receptor Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Pharmaceutical Industries Ltd. Company Information Table 75. Teva Pharmaceutical Industries Ltd. Business Overview Table 76. Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Portfolio Table 78. Teva Pharmaceutical Industries Ltd. Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sanofi Angiopoietin 1 Receptor Product Portfolio Table 83. Sanofi Recent Development Table 84. Pfizer Inc. Company Information Table 85. Pfizer Inc. Business Overview Table 86. Pfizer Inc. Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Pfizer Inc. Angiopoietin 1 Receptor Product Portfolio Table 88. Pfizer Inc. Recent Development Table 89. PharmAbcine, Inc. Company Information Table 90. PharmAbcine, Inc. Business Overview Table 91. PharmAbcine, Inc. Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. PharmAbcine, Inc. Angiopoietin 1 Receptor Product Portfolio Table 93. PharmAbcine, Inc. Recent Development Table 94. Exelixis, Inc. Company Information Table 95. Exelixis, Inc. Business Overview Table 96. Exelixis, Inc. Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Exelixis, Inc. Angiopoietin 1 Receptor Product Portfolio Table 98. Exelixis, Inc. Recent Development Table 99. Eddingpharm Company Information Table 100. Eddingpharm Business Overview Table 101. Eddingpharm Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Eddingpharm Angiopoietin 1 Receptor Product Portfolio Table 103. Eddingpharm Recent Development Table 104. Deciphera Pharmaceuticals, LLC Company Information Table 105. Deciphera Pharmaceuticals, LLC Business Overview Table 106. Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Portfolio Table 108. Deciphera Pharmaceuticals, LLC Recent Development Table 109. Aerpio Therapeutics, Inc. Company Information Table 110. Aerpio Therapeutics, Inc. Business Overview Table 111. Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Portfolio Table 113. Aerpio Therapeutics, Inc. Recent Development Table 114. North America Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 115. North America Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 116. North America Angiopoietin 1 Receptor Sales Market Share by Country (2021-2026) Table 117. North America Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 118. North America Angiopoietin 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 119. North America Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Angiopoietin 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Angiopoietin 1 Receptor Market Share by Country (2021-2026) Table 122. North America Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Angiopoietin 1 Receptor Market Share Forecast by Country (2027-2032) Table 124. Europe Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 125. Europe Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 126. Europe Angiopoietin 1 Receptor Sales Market Share by Country (2021-2026) Table 127. Europe Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 128. Europe Angiopoietin 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Angiopoietin 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Angiopoietin 1 Receptor Market Share by Country (2021-2026) Table 132. Europe Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Angiopoietin 1 Receptor Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 136. Asia-Pacific Angiopoietin 1 Receptor Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 138. Asia-Pacific Angiopoietin 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Angiopoietin 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Angiopoietin 1 Receptor Market Share by Country (2021-2026) Table 142. Asia-Pacific Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Angiopoietin 1 Receptor Market Share Forecast by Country (2027-2032) Table 144. Latin America Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Latin America Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 146. Latin America Angiopoietin 1 Receptor Sales Market Share by Country (2021-2026) Table 147. Latin America Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 148. Latin America Angiopoietin 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Angiopoietin 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Angiopoietin 1 Receptor Market Share by Country (2021-2026) Table 152. Latin America Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Angiopoietin 1 Receptor Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 156. Middle East and Africa Angiopoietin 1 Receptor Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 158. Middle East and Africa Angiopoietin 1 Receptor Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Angiopoietin 1 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Angiopoietin 1 Receptor Market Share by Country (2021-2026) Table 162. Middle East and Africa Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Angiopoietin 1 Receptor Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Angiopoietin 1 Receptor Distributors List Table 167. Angiopoietin 1 Receptor Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Angiopoietin 1 Receptor Image Figure 2. Global Angiopoietin 1 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiopoietin 1 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Angiopoietin 1 Receptor Sales (2021-2032) & (W Units) Figure 5. AP-185 Image Figure 6. Global AP-185 Sales YoY Growth (2021-2032) & (W Units) Figure 7. ARP-1536 Image Figure 8. Global ARP-1536 Sales YoY Growth (2021-2032) & (W Units) Figure 9. MAN-01 Image Figure 10. Global MAN-01 Sales YoY Growth (2021-2032) & (W Units) Figure 11. PMC-001 Image Figure 12. Global PMC-001 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Angiopoietin 1 Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Angiopoietin 1 Receptor Market Share by Type 2025 VS 2032 Figure 17. North America Angiopoietin 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 18. North America Angiopoietin 1 Receptor Sales Market Share in Value by Type in 2025 Figure 19. Europe Angiopoietin 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 20. Europe Angiopoietin 1 Receptor Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Angiopoietin 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Angiopoietin 1 Receptor Sales Market Share in Value by Type in 2025 Figure 23. Latin America Angiopoietin 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Angiopoietin 1 Receptor Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Angiopoietin 1 Receptor Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Angiopoietin 1 Receptor Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Angiopoietin 1 Receptor Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Ureter Cancer Image Figure 30. Global Ureter Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 31. Neuroendocrine Tumors Image Figure 32. Global Neuroendocrine Tumors Sales YoY Growth (2021-2032) & (W Units) Figure 33. Ovarian Cancer Image Figure 34. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 35. Bladder Cancer Image Figure 36. Global Bladder Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Angiopoietin 1 Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Angiopoietin 1 Receptor Market Share by Application 2025 VS 2032 Figure 41. North America Angiopoietin 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 42. North America Angiopoietin 1 Receptor Sales Market Share in Value by Application in 2025 Figure 43. Europe Angiopoietin 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 44. Europe Angiopoietin 1 Receptor Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Angiopoietin 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Angiopoietin 1 Receptor Sales Market Share in Value by Application in 2025 Figure 47. Latin America Angiopoietin 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Angiopoietin 1 Receptor Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Angiopoietin 1 Receptor Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Angiopoietin 1 Receptor Sales Market Share in Value by Application in 2025 Figure 51. North America Angiopoietin 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Angiopoietin 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Angiopoietin 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Angiopoietin 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Angiopoietin 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Angiopoietin 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Angiopoietin 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Angiopoietin 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Angiopoietin 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Angiopoietin 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Angiopoietin 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Angiopoietin 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Angiopoietin 1 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Angiopoietin 1 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Angiopoietin 1 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Angiopoietin 1 Receptor Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Angiopoietin 1 Receptor Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • AP-185
  • ARP-1536
  • MAN-01
  • PMC-001
  • Others
Applications
  • Ureter Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • PharmAbcine, Inc.
  • Exelixis, Inc.
  • Eddingpharm
  • Deciphera Pharmaceuticals, LLC
  • Aerpio Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angiopoietin 1 Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Angiopoietin 1 Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Angiopoietin 1 Receptor Market by Type
  6. 1.3.1 AP-185
  7. 1.3.2 ARP-1536
  8. 1.3.3 MAN-01
  9. 1.3.4 PMC-001
  10. 1.3.5 Others
  11. 1.4 Global Angiopoietin 1 Receptor Market Size by Type
  12. 1.4.1 Global Angiopoietin 1 Receptor Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Angiopoietin 1 Receptor Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Angiopoietin 1 Receptor Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Angiopoietin 1 Receptor Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Angiopoietin 1 Receptor Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Angiopoietin 1 Receptor Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Angiopoietin 1 Receptor Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Angiopoietin 1 Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Angiopoietin 1 Receptor Industry Trends
  2. 2.2 Angiopoietin 1 Receptor Industry Drivers
  3. 2.3 Angiopoietin 1 Receptor Industry Opportunities and Challenges
  4. 2.4 Angiopoietin 1 Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Angiopoietin 1 Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Angiopoietin 1 Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Angiopoietin 1 Receptor Price (2021-2026)
  4. 3.4 Global Angiopoietin 1 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Angiopoietin 1 Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Angiopoietin 1 Receptor Company, Product Type & Application
  7. 3.7 Global Angiopoietin 1 Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Angiopoietin 1 Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Angiopoietin 1 Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Angiopoietin 1 Receptor Tier 1, Tier 2, and Tier 3
4 Angiopoietin 1 Receptor Regional Status and Outlook
  1. 4.1 Global Angiopoietin 1 Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Angiopoietin 1 Receptor Historic Market Size by Region
  3. 4.2.1 Global Angiopoietin 1 Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Angiopoietin 1 Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Angiopoietin 1 Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Angiopoietin 1 Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Angiopoietin 1 Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Angiopoietin 1 Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Angiopoietin 1 Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Angiopoietin 1 Receptor by Application
  1. 5.1 Angiopoietin 1 Receptor Market by Application
  2. 5.1.1 Ureter Cancer
  3. 5.1.2 Neuroendocrine Tumors
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Bladder Cancer
  6. 5.1.5 Others
  7. 5.2 Global Angiopoietin 1 Receptor Market Size by Application
  8. 5.2.1 Global Angiopoietin 1 Receptor Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Angiopoietin 1 Receptor Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Angiopoietin 1 Receptor Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Angiopoietin 1 Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Angiopoietin 1 Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Angiopoietin 1 Receptor Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Angiopoietin 1 Receptor Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Angiopoietin 1 Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd.
  2. 6.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Angiopoietin 1 Receptor Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Pfizer Inc.
  14. 6.3.1 Pfizer Inc. Company Information
  15. 6.3.2 Pfizer Inc. Business Overview
  16. 6.3.3 Pfizer Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc. Angiopoietin 1 Receptor Product Portfolio
  18. 6.3.5 Pfizer Inc. Recent Developments
  19. 6.4 PharmAbcine, Inc.
  20. 6.4.1 PharmAbcine, Inc. Company Information
  21. 6.4.2 PharmAbcine, Inc. Business Overview
  22. 6.4.3 PharmAbcine, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PharmAbcine, Inc. Angiopoietin 1 Receptor Product Portfolio
  24. 6.4.5 PharmAbcine, Inc. Recent Developments
  25. 6.5 Exelixis, Inc.
  26. 6.5.1 Exelixis, Inc. Company Information
  27. 6.5.2 Exelixis, Inc. Business Overview
  28. 6.5.3 Exelixis, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Exelixis, Inc. Angiopoietin 1 Receptor Product Portfolio
  30. 6.5.5 Exelixis, Inc. Recent Developments
  31. 6.6 Eddingpharm
  32. 6.6.1 Eddingpharm Company Information
  33. 6.6.2 Eddingpharm Business Overview
  34. 6.6.3 Eddingpharm Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eddingpharm Angiopoietin 1 Receptor Product Portfolio
  36. 6.6.5 Eddingpharm Recent Developments
  37. 6.7 Deciphera Pharmaceuticals, LLC
  38. 6.7.1 Deciphera Pharmaceuticals, LLC Company Information
  39. 6.7.2 Deciphera Pharmaceuticals, LLC Business Overview
  40. 6.7.3 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Portfolio
  42. 6.7.5 Deciphera Pharmaceuticals, LLC Recent Developments
  43. 6.8 Aerpio Therapeutics, Inc.
  44. 6.8.1 Aerpio Therapeutics, Inc. Company Information
  45. 6.8.2 Aerpio Therapeutics, Inc. Business Overview
  46. 6.8.3 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Portfolio
  48. 6.8.5 Aerpio Therapeutics, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Angiopoietin 1 Receptor Sales by Country
  2. 7.1.1 North America Angiopoietin 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Angiopoietin 1 Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Angiopoietin 1 Receptor Market Size by Country
  6. 7.2.1 North America Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Angiopoietin 1 Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Angiopoietin 1 Receptor Sales by Country
  2. 8.1.1 Europe Angiopoietin 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Angiopoietin 1 Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Angiopoietin 1 Receptor Market Size by Country
  6. 8.2.1 Europe Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Angiopoietin 1 Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Angiopoietin 1 Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Angiopoietin 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Angiopoietin 1 Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Angiopoietin 1 Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Angiopoietin 1 Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Angiopoietin 1 Receptor Sales by Country
  2. 10.1.1 South America Angiopoietin 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Angiopoietin 1 Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Angiopoietin 1 Receptor Market Size by Country
  6. 10.2.1 South America Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Angiopoietin 1 Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Angiopoietin 1 Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Angiopoietin 1 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Angiopoietin 1 Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Angiopoietin 1 Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Angiopoietin 1 Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Angiopoietin 1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Angiopoietin 1 Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Angiopoietin 1 Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Angiopoietin 1 Receptor Value Chain Analysis
  2. 12.1.1 Angiopoietin 1 Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Angiopoietin 1 Receptor Production Mode & Process
  7. 12.2 Angiopoietin 1 Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Angiopoietin 1 Receptor Distributors
  10. 12.2.3 Angiopoietin 1 Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst